During the past decade, Centre Cardiologique du Nord conducted 35 clinical trials. In the 10-year time frame, 35 clinical trials started and 3 clinical trials were completed, i.e. on average, 8.6% percent of trials that started reached the finish line to date. In the past 5 years, 18 clinical trials started and 2 clinical trials were completed. i.e. 11.1% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Centre Cardiologique du Nord" #1 sponsor was "French Cardiology Society" with 5 trials, followed by "LivaNova" with 4 trials sponsored, "Withings" with 3 trials sponsored, "Assistance Publique - Hôpitaux de Paris" with 2 trials sponsored and "Centre Cardiologique du Nord" with 2 trials sponsored. Other sponsors include 35 different institutions and companies that sponsored additional 41 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Centre Cardiologique du Nord" #1 collaborator was "Boston Scientific Corporation" with 3 trials as a collaborator, "Assistance Publique - Hôpitaux de Paris" with 2 trials as a collaborator, "Henri Mondor University Hospital" with 2 trials as a collaborator, "Ministry of Health, France" with 2 trials as a collaborator and "Abbott" with 1 trials as a collaborator. Other collaborators include 24 different institutions and companies that were collaborators in the rest 34 trials.

According to Clinical.Site data, the most researched conditions in "Centre Cardiologique du Nord" are "Atrial Fibrillation" (9 trials), "Coronary Artery Disease" (5 trials), "Heart Failure" (5 trials), "Aortic Valve Stenosis" (2 trials) and "Arrythmia, Cardiac" (2 trials). Many other conditions were trialed in "Centre Cardiologique du Nord" in a lesser frequency.

Most popular intervention types in "Centre Cardiologique du Nord" are "Device" (26 trials), "Other" (12 trials), "Procedure" (10 trials), "Drug" (6 trials) and "Diagnostic Test" (4 trials). Other intervention types were less common.

The name of intervention was led by "AF Detection" (1 trials), "AF detection by ECG" (1 trials), "ATE score" (1 trials), "Ablation by radiofrequency of low-voltage areas" (1 trials) and "Angio" (1 trials). Other intervention names were less common.

The vast majority of trials in "Centre Cardiologique du Nord" are 56 trials for "All" genders.

Currently, there are NaN active trials in "Centre Cardiologique du Nord". undefined are not yet recruiting, 13 are recruiting, 7 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 30 completed trials in Centre Cardiologique du Nord, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Centre Cardiologique du Nord, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 10 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 7 trials, and there were also 20 trials that are defined as “Not Applicable".